2003
DOI: 10.4049/jimmunol.171.1.226
|View full text |Cite
|
Sign up to set email alerts
|

T Cell Receptor Revision Does Not Solely Target Recent Thymic Emigrants

Abstract: CD4+Vβ5+ T cells enter one of two tolerance pathways after recognizing a peripherally expressed superantigen encoded by an endogenous retrovirus. One pathway leads to deletion, while the other, termed TCR revision, results in cellular rescue upon expression of an alternate TCR that no longer recognizes the tolerogen. TCR revision requires the rearrangement of novel TCR β-chain genes and depends on recombinase-activating gene (RAG) expression in peripheral T cells. In line with recent findings that RAG+ splenic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
52
0

Year Published

2004
2004
2022
2022

Publication Types

Select...
3
3

Relationship

2
4

Authors

Journals

citations
Cited by 40 publications
(52 citation statements)
references
References 57 publications
0
52
0
Order By: Relevance
“…Furthermore, TCR revision can occur in V␤5 ϩ CD4 ϩ T cells from mice thymectomized up to 2 mo previously (11). These results indicate that TCR revision does not target recent thymic emigrants with an immature transitional phenotype, cells known to disappear within 2 wk after removal of the thymus (18).…”
mentioning
confidence: 69%
See 4 more Smart Citations
“…Furthermore, TCR revision can occur in V␤5 ϩ CD4 ϩ T cells from mice thymectomized up to 2 mo previously (11). These results indicate that TCR revision does not target recent thymic emigrants with an immature transitional phenotype, cells known to disappear within 2 wk after removal of the thymus (18).…”
mentioning
confidence: 69%
“…Water-lysed PBL, splenocytes, lymph node (LN) cells, and bone marrow cells were stained as described previously (11). In experiments analyzing surface phenotype, splenocytes were depleted of B220 ϩ cells using B220 microbeads and an AutoMACS column according to the manufacturer's protocol (Miltenyi Biotec, Auburn, CA).…”
Section: Cell Surface Staining and Flow Cytometrymentioning
confidence: 99%
See 3 more Smart Citations